| Accession | HRS899422 |
|---|---|
| BioSample Accession | SAMC2930797 |
| Individual accession | HRI684575 |
| Study accession | HRA005098 |
| Sample name | P33_3_BLDC |
| Sample title | P33_3_BLDC |
| Collection date | 2021-11-08 |
| Sample Type | Disease |
| Description | Tislelizumab plus cetuximab and irinotecan in patients with previously treated MSS and RAS wild-type advanced colorectal cancer |
| Tissue | blood cell |
| Release date | 2024-06-01 |